Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MassmedicaWAR:MSM +2.27%84 EV-to-FCF is -26.51 as of Jul. 17, 2026. GuruFocus rates WAR:MSM with a GF Score™ of 84/100 and a GF Value™ of zł4.31 (Fairly Valued). The stock has 4 warning signs investors should review. Among 414 Medical Devices & Instruments companies, Massmedica ranks worse than 241545.65% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Massmedica's Enterprise Value is zł19.04 Mil.
Massmedica's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was zł-0.72 Mil. Therefore, Massmedica's EV-to-FCF for today is -26.51.
The historical rank and industry rank for Massmedica's EV-to-FCF or its related term are showing as below:
WAR:MSM'
s EV-to-FCF Range Over the Past 10 Years
Min: -527.43 Med: -7.87 Max: 212.31
Current: -25.77
During the past 10 years, the highest EV-to-FCF of Massmedica was 212.31. The lowest was -527.43. And the median was -7.87.
WAR:MSM's EV-to-FCF is ranked worse than 100% of 414
companies
in the Medical Devices & Instruments industry
Industry Median: 23.635
vs WAR:MSM: -25.77
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Massmedica's share price for today is zł4.50.
Massmedica's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł0.281.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Massmedica EV-to-FCF Related Terms
Massmedica EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Massmedica's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Massmedica's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Massmedica EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Massmedica's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Massmedica's EV-to-FCF falls into.
Massmedica's current Enterprise Value is zł19.04 Mil.
Massmedica's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł-0.72 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Massmedica (WAR:MSM) has a EV-to-FCF of -26.51 as of Jul. 17, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Massmedica and its competitors. According to the industry distribution chart, Massmedica ranks #999999 out of 414 companies in the Medical Devices & Instruments industry.
Is Massmedica's EV-to-FCF too high?
Massmedica's current EV-to-FCF is -26.51. Based on the distribution chart, Massmedica ranks #999999 out of 414 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Massmedica has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Massmedica's EV-to-FCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Massmedica ranks #999999 out of 414 companies for EV-to-FCF. This places Massmedica in the lower half of its industry. The industry median EV-to-FCF is 23.64. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.64, based on 414 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Massmedica and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Massmedica's current EV-to-FCF is -26.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Massmedica stock overvalued right now?
Based on GuruFocus' analysis, Massmedica (WAR:MSM) is currently considered Fairly Valued. The stock's GF Value™ is zł4.31, compared to a current price of zł4.50 — trading 4.4% above its estimated fair value. The current EV-to-FCF is -26.51. Massmedica's overall GF Score™ is 84/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Massmedica (WAR:MSM), the current EV-to-FCF is -26.51 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Massmedica (WAR:MSM) Overvalued in 2026?
Based on GuruFocus' analysis, Massmedica stock appears to be overvalued.
The current stock price of zł4.50 is trading 4.4% above its estimated GF Value™ of zł4.31.
GuruFocus considers Massmedica to be Fairly Valued.
Key valuation signals for WAR:MSM:
EV-to-FCF: -26.51
GF Value™: zł4.31 vs. price of zł4.50 (4.4% above fair value)
No single metric tells the full story. See the WAR:MSM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Massmedica SA is operating in the areas of reconstructive, regenerative, anti-aging and aesthetic medicine. It deals in the distribution of implants and other medical materials used in the treatment of diseases of the musculoskeletal system and in regenerative medicine.
84GF Score
Get the complete analysis for WAR:MSM
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:MSM has been successfully added to your 
